Breast Cancer | Tumor

Living One Day Longer Than My Father

January 18th 2021, 5:00pm


As a cancer survivor, I’ve found many reasons to celebrate. Here’s one more.

Communication is Key When Navigating Cancer and a Marriage

January 15th 2021, 2:00pm


Janice and Rex Cowden sat down for an interview to discuss how to navigate a cancer diagnosis as a couple, and that communication is not only the key to a better cancer journey but a better marriage.

To Tell or Not to Tell About My Mastectomy

January 13th 2021, 5:00pm


A cancer survivor discusses how she decides to discuss her mastectomy and the acceptance of her body after treatment for cancer.

Newly Diagnosed with Cancer? Remember You’re 'Not a Statistic'

January 11th 2021, 4:00pm


It's easy to get lost in the statistics of survivorship, but it's important for newly diagnosed patients with cancer to remember that they are not a statistic.

Keytruda and Chemotherapy Combination Broadens Number of Treatable Patients with TNBC

January 8th 2021, 10:00pm


In an interview with CURE®, lead study investigator of the Keynote 355 trial, Dr. Hope S Rugo, discusses the results of the study that led to the FDA approval of the combination therapy and what further data means for certain patients with metastatic triple-negative breast cancer.

FDA Fast Track of Novel Agent May Open Doors in Subset of Breast Cancer

January 8th 2021, 7:00pm


The FDA’s fast track designation for ARX788 to treat patients with advanced or metastatic HER2-positive breast cancer who have received at least one previous anti-HER2-based treatment in the metastatic setting, may open the doors to an accelerated approval.

ELLE Magazine’s Nina Garcia Offers Hope to Women Who Are at Genetic Risk for, Diagnosed With Breast Cancer

January 7th 2021, 10:00pm


After being diagnosed with the BARD1 gene and undergoing a preventative double mastectomy, Nina Garcia shares her story to raise awareness and offer hope for other women.

Phase 3 RxPONDER Trial May Empower Patients with Breast Cancer on Their Treatment Decisions

January 7th 2021, 7:00pm


In a recent trial, the addition of chemotherapy to endocrine therapy showed clinical benefit in premenopausal women with lymph node-positive, HR-positive, HER2-negative breast cancer.

Flatties Unite: The Choice to Forego Breast Reconstruction

January 6th 2021, 5:00pm


Choosing to forego breast reconstruction after breast cancer surgery can cause one to feel like the lone ranger, but that feeling doesn’t last long, especially upon the discovery of an entire flattie tribe.

How Three Clinical Trials Have Shaped the HER2+ Breast Cancer Treatment Landscape

January 5th 2021, 2:00pm


Here's how 3 clinical trials have shaped the overall landscape for patients with HER2 positive breast cancer.